Cancer Scan Co., Ltd. Fukuyoshi, CEO of Cancer Scan, will give a special lecture at “Medical Design Summit 2 022”

Cancer Scan Co., Ltd.
Fukuyoshi, CEO of Cancer Scan, gave a special lecture at “Medical Design Summit 2022”
Hachioji City Lecture on a model for introducing a social impact bond in a project to improve the rate of colorectal cancer screening and detailed examinations

Cancer Scan Co., Ltd. (Headquarters: Shinagawa-ku, Tokyo;
Representative: Jun Fukuyoshi, President and CEO; hereinafter “Cancer Scan”), which supports the promotion of preventive medicine, is a general incorporated association Japan Medical Design. We are pleased to inform you that we will be presenting at the “Medical Design Summit 2022” hosted by the center.
[Imaged15303-42-42bbeb6035bcf905116e-0.png&s3=15303-42-94ac94c985373df31d1f4be8e4ccf9a4-602x295.png
            Special site https://mdc-japan.org/design-summit2022/ On November 15th (Tuesday), Fukuyoshi gave a special lecture titled “Considering the possibility of public-private partnership and the watershed of success of SIB from the efforts of Hachioji City”. At the same time, I would like to talk about the social impact bond introduction model in the colorectal cancer screening and detailed examination rate improvement project.
〇 About “Medical Design Summit 2022”
Event name: Medical Design Summit 2022
Special site https://mdc-japan.org/design-summit2022/
Theme: BEYOND BORDERS Crossing boundaries with medical design Organizer: Japan Medical Design Center
Date: 11/15 (Tue) 20:00-21:20 Special lecture
11/17 (Thursday) 20:00-21:20 public meeting
11/18 (Friday) 20:00-21:00 Special lecture
11/19 (Sat) 10:30-19:00 Summit
Format: Streamed on YouTube Live*1
*1: Registration is required for viewing. With one ticket, you can watch all programs for all dates. Please refer to the special site for details.
〇 About “Medical Design Summit 2022” Special Lecture
Theme: Considering the possibility of public-private partnership and the watershed of SIB’s success from Hachioji City’s efforts
Speaker: Mr. Ken Shindo, chief examiner, Adult Health Checkup Division, Health and Medical Department, Hachioji City
Jun Fukuyoshi, President and CEO, Cancer Scan Co., Ltd.
Mr. Yuto Yoshida, Representative Director, Japan GR Association (Moderator) Date: 11/15 (Tue) 20:00-21:20
Cancer Scan will continue to promote the dissemination of information that contributes to the development of the medical industry. ■ About Cancer Scan
To achieve its mission of “making people and society healthier”, Cancer Scan combines data science with marketing, behavioral economics, and public health expertise to encourage specific health checkups and increase the severity of lifestyle-related diseases. We are developing various projects that support the promotion of preventive medicine in Japan, such as encouraging people to receive preventive medicine, recommending cancer screening, and developing new projects related to preventive medicine. Through supporting the implementation of various preventive medicine projects in a total of more than 700 municipalities, we aim to realize a society where there is no friction in behavioral changes to become healthy, while changing communication and social mechanisms.
■Company profile
Company name: Cancer Scan Co., Ltd.
Location: Gotanda PLACE 2F, 1-3-8 Nishi-Gotanda, Shinagawa-ku, Tokyo 141-0031 Established: November 2008
Representative: Jun Fukuyoshi, President and Representative Director HP: https://cancerscan.jp/

Details about this release:
https://prtimes.jp/main/html/rd/p/000000042.000015303.html


rehow

Leave a Reply

Your email address will not be published.

%d bloggers like this: